Trial intelligence / Profile preview

ERI: Enteral vs Intravenous Fluid in Critically Ill Patients

NCT05595395Unknown

Sponsor
Medical University of Vienna
Start
Feb 2023
Primary completion
Dec 2024
Countries
1
01

Overview

Randomised, open-label trial in Electrolyte imbalance, Volume overload and hyperglycemic hyperosmolar syndrome (HHS), sponsored by Medical University of Vienna. Primary endpoints: Regurgitation and Serum Sodium. Status: unknown.

02

Conditions

Electrolyte imbalanceVolume overloadhyperglycemic hyperosmolar syndrome (HHS)

Beyond the preview

Go deeper on NCT05595395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05595395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call